BioVie
BIVI
10 hedge funds and large institutions have $4.62M invested in BioVie in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, 5 reducing their positions, and 3 closing their positions.
75% more capital invested
Capital invested by funds: $2.64M → $4.62M (+$1.98M)
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
25% more funds holding
Funds holding: 8 → 10 (+2)
0.01% more ownership
Funds ownership: 0.01% → 0.02% (+0.01%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$2.59M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$759K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$605K |
| 4 |
SFS
Sowell Financial Services
North Little Rock,
Arkansas
|
+$57K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$8.56K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
S
swisspartners
Vaduz,
Liechtenstein
|
-$590K |
| 2 |
SC
Saltoro Capital
Dallas,
Texas
|
-$260K |
| 3 |
Capstone Investment Advisors
New York
|
-$222K |
| 4 |
SC
Shay Capital
New York
|
-$106K |
| 5 |
Millennium Management
New York
|
-$25.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Ameriprise
Minneapolis,
Minnesota
| $1.76M | +$2.59M | +909 | New |
|
|
S
2
swisspartners
Vaduz,
Liechtenstein
| $1.05M | -$590K | -207 | -28% |
|
|
3
Vanguard Group
Malvern,
Pennsylvania
| $514K | +$759K | +266 | New |
|
|
4
Millennium Management
New York
| $447K | -$25.7K | -9 | -4% |
|
|
5
Geode Capital Management
Boston,
Massachusetts
| $410K | +$605K | +212 | New |
|
|
SC
6
Shay Capital
New York
| $394K | -$106K | -37 | -15% |
|
|
SFS
7
Sowell Financial Services
North Little Rock,
Arkansas
| $26K | +$57K | +20 | New |
|
8
Citigroup
New York
| $9K | -$2.85K | -1 | -17% |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $5K | +$8.56K | +3 | New |
|
10
Osaic Holdings
Scottsdale,
Arizona
| $4K | -$22.8K | -8 | -80% |
|
11
Morgan Stanley
New York
| $1K | -$22.8K | -8 | Closed |
|
|
SC
12
Saltoro Capital
Dallas,
Texas
| – | -$260K | -150 | Closed |
|
|
13
Capstone Investment Advisors
New York
| – | -$222K | -128 | Closed |
|
BIVI Hedge Fund Activity: Q1 2021 in Review
10 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in BioVie (BIVI) for Q1 2021, worth a combined $4.62M — up 75% from $2.64M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new BIVI positions and 3 closed out — a net gain of 2 holders — while 0 added to existing stakes and 5 trimmed.
The largest buyer was Ameriprise, opening a new position worth an estimated $2.59M. The largest seller was swisspartners, cutting an estimated $590K.
- 10 institutional investors held BioVie (BIVI) as of Q1 2021, up from 8 in Q4 2020.
- Funds reported $4.62M of BioVie stock for Q1 2021, up 75% quarter-over-quarter.
- 5 funds opened new BioVie positions in Q1 2021 and 3 closed out, a net change of +2 holders.
- The largest BioVie buyer in Q1 2021 was Ameriprise, an estimated $2.59M added.
- The largest BioVie seller in Q1 2021 was swisspartners, an estimated $590K sold.
Based on aggregated 13F filings for Q1 2021.